共 97 条
[62]
Pathway-Centric Integrative Analysis Identifies RRM2 as a Prognostic Marker in Breast Cancer Associated with Poor Survival and Tamoxifen Resistance
[J].
NEOPLASIA,
2014, 16 (05)
:390-402
[70]
Shinoda Shuhei, 2018, Oncotarget, V9, P28434, DOI 10.18632/oncotarget.25421